Concerning Chapter 5 - Human Albumin; in Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives, 4th ed. Transfus Med Hemother 2009;36(6):399-407.
作者信息
Farrugia Albert
机构信息
Plasma Protein Therapeutics Association, Annapolis, MD, USA.
出版信息
Transfus Med Hemother. 2010 Apr;37(2):98-99. doi: 10.1159/000293349. Epub 2010 Mar 15.
Abstract
摘要
相似文献
1
Concerning Chapter 5 - Human Albumin; in Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives, 4th ed. Transfus Med Hemother 2009;36(6):399-407.关于第5章——人血白蛋白；载于《血液成分和血浆衍生物治疗横断面指南》第4版。《输血医学与血液学治疗》2009年；36(6):399 - 407。
Transfus Med Hemother. 2010 Apr;37(2):98-99. doi: 10.1159/000293349. Epub 2010 Mar 15.
2
Concerning Hänecke P, Klouche M: Thrombelastography Today: Practicability and Analytical Power. Transfus Med Hemother 2007;34:421-428.关于哈内克P、克洛什M：《今日血栓弹力图：实用性与分析能力》。《输血医学与血液学疗法》2007年；34卷：第421 - 428页。
Transfus Med Hemother. 2008;35(4):324-326. doi: 10.1159/000143229. Epub 2008 Jul 21.
3
Concerning Fiedler S. A. et al.: Evaluation of the in vitro Function of Platelet Concentrates from Pooled Buffy Coats or Apheresis. Transfus Med Hemother 2020.关于菲德勒·S.A.等人：来自混合白膜层或单采血小板浓缩物的体外功能评估。《输血医学与血液学疗法》2020年。
Clin Lab. 2020 Mar 1;66(3). doi: 10.7754/Clin.Lab.2020.200209.
4
Excluding Occult Hepatitis B Infection before Assigning False-Positive Status to Non-Repeatable NAT Reactivity: Concerning Stolz et al. "Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country" [Transfus Med Hemother. 2019 Apr;46(2):104-10].在将不可重复的核酸检测反应性判定为假阳性之前排除隐匿性乙型肝炎感染：关于施托尔茨等人的《个体献血核酸检测的安全检测算法：在低流行率国家的10年经验》[《输血医学与血液学》。2019年4月；46(2):104 - 10]。
Transfus Med Hemother. 2020 Jun;47(3):272-274. doi: 10.1159/000502552. Epub 2019 Aug 29.
5
Regarding Microbiological Control of Cellular Products: The Relevance of the Cellular Matrix, Incubation Temperature, and Atmosphere for the Detection Performance of Automated Culture Systems [Transfus Med Hemother. 2020;47:254-63].关于细胞产品的微生物控制：细胞基质、孵育温度和气氛对自动培养系统检测性能的相关性[《输血医学与血液学》。2020年；47:254 - 63]
Transfus Med Hemother. 2021 May;48(3):196-197. doi: 10.1159/000515029. Epub 2021 Mar 15.
6
Response to Regarding Microbiological Control of Cellular Products: The Relevance of the Cellular Matrix, Incubation Temperature, and Atmosphere for the Detection Performance of Automated Culture Systems. Transfus Med Hemother. 2020;47:254-63.关于细胞制品微生物控制的回应：细胞基质、培养温度和气氛对自动化培养系统检测性能的相关性。《输血医学与血液学疗法》。2020年；47：254 - 63。
Transfus Med Hemother. 2021 May;48(3):198. doi: 10.1159/000515028. Epub 2021 Mar 15.
7
Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives (4th revised edition, 2008) - Suspension of Chapter 5 'Human Albumin'.《血液成分和血浆衍生物治疗的横断面指南》（2008年第4版修订本）——第5章“人血白蛋白”的停用
Transfus Med Hemother. 2011;38(1):71. doi: 10.1159/000324247.
8
Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives: Chapter 5 Human Albumin - Revised.血液成分及血浆衍生物治疗的横断面指南：第5章 人血白蛋白 - 修订版
Transfus Med Hemother. 2016 May;43(3):223-32. doi: 10.1159/000446043. Epub 2016 May 3.
9
Persistent inter-observer variability of breast density assessment using BI-RADS® 5th edition guidelines.BI-RADS® 5 版指南评估乳腺密度的观察者间持续性变异性。
Clin Imaging. 2022 Mar;83:21-27. doi: 10.1016/j.clinimag.2021.11.034. Epub 2021 Dec 10.
10
Corrigendum to "Pioneers & Pathfinders: Canadian Surgeons and the Introduction of Blood Transfusion in War Surgery" [Transfus Med Rev 2008; 22: 77-86].《“先驱者与开拓者：加拿大外科医生与战争外科输血技术的引入”勘误》[《输血医学评论》2008年；22: 77 - 86]
Transfus Med Rev. 2023 Apr;37(2):150724. doi: 10.1016/j.tmrv.2023.03.002. Epub 2023 Apr 19.
引用本文的文献
1
Significant reduction of red blood cell transfusion requirements by changing from a double-unit to a single-unit transfusion policy in patients receiving intensive chemotherapy or stem cell transplantation.在接受强化化疗或干细胞移植的患者中，通过将输血策略从双单位改为单单位，可显著减少红细胞输血需求。
Haematologica. 2012 Jan;97(1):116-22. doi: 10.3324/haematol.2011.047035. Epub 2011 Sep 20.
2
As for the Past, as for 2010.至于过去，就像2010年那样。
Transfus Med Hemother. 2010 Feb;37(1):5-6. doi: 10.1159/000279152.
本文引用的文献
2
Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.羟乙基淀粉（HES）与其他液体疗法：对肾功能的影响。
Cochrane Database Syst Rev. 2010 Jan 20(1):CD007594. doi: 10.1002/14651858.CD007594.pub2.
3
Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis.静脉注射白蛋白对肝硬化合并自发性细菌性腹膜炎患者内毒素清除、细胞因子及一氧化氮生成的影响。
Scand J Gastroenterol. 2009;44(5):619-25. doi: 10.1080/00365520902719273.
4
Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.快速降解羟乙基淀粉溶液会损害心脏手术后的凝血功能：一项前瞻性随机试验。
Anesth Analg. 2009 Jan;108(1):30-6. doi: 10.1213/ane.0b013e31818c1282.
5
The risk associated with hyperoncotic colloids in patients with shock.休克患者使用高渗胶体的相关风险。
Intensive Care Med. 2008 Dec;34(12):2157-68. doi: 10.1007/s00134-008-1225-2. Epub 2008 Aug 7.
6
The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials.羟乙基淀粉130/0.4（6%）对大手术中失血及血液制品使用的影响：随机临床试验的汇总分析
Anesth Analg. 2008 Aug;107(2):382-90. doi: 10.1213/ane.0b013e31817e6eac.
7
8
Molecular adsorbent recirculating system (MARS) application in liver failure: clinical and hemodepurative results in 22 patients.分子吸附循环系统（MARS）在肝衰竭中的应用：22例患者的临床及血液净化结果
Int J Artif Organs. 2006 Feb;29(2):207-18. doi: 10.1177/039139880602900207.
9
A comparison of albumin and saline for fluid resuscitation in the intensive care unit.重症监护病房中白蛋白与生理盐水用于液体复苏的比较。
N Engl J Med. 2004 May 27;350(22):2247-56. doi: 10.1056/NEJMoa040232.
10
Safety of human albumin--serious adverse events reported worldwide in 1998-2000.人血白蛋白的安全性——1998 - 2000年全球报告的严重不良事件
Br J Anaesth. 2003 Nov;91(5):625-30. doi: 10.1093/bja/aeg233.
Zotero 插件